Global Acne Treatment Market Forecast till 2027

Global Acne Treatment Market Forecast till 2027

$4450 – $6250

The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027.

SKU: MRFR210196 Category: Tags: , , , , ,

Description

Global Acne Treatment Market: Information by Acne Type (Moderate, Mild, Moderate to Severe), by Treatment (Medication, Therapeutic Devices), by Drug Type (OTC, Prescription), by Route of Administration (Topical, Oral, Injectable), by End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027

Acne Treatment Market Overview

The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027. Acne treatment includes the organization of a few types of prescriptions and balms to ease up the tone of influenced regions. A decent eating regimen is likewise viewed as a vital factor for acne treatment, and this factor has assumed a significant part in the development of the acne treatment market. Also, the rising requirement for further developed drugs for acne treatment has acquired voluminous interests in the acne treatment market.
The global acne treatment market is anticipated to witness a healthy market growth during the review period owing to the highest market value of USD 5,383.05 million in 2019. The growth of the global market is attributed to the rising prevalence of acne vulgaris, growing sedentary lifestyle and unhealthy food habits, High influence of social media, and brand endorsements. However, security issues related to the products being applied for acne treatment and the Failure of pivotal clinical trials for key candidates are expected to restrain the global market growth during the review period.

Market Segmentation
The acne treatment market has been classified into acne type, treatment, drug type, route of administration, and end-user.
Based on acne type, the global market has been classified into moderate acne, mild acne, moderate to severe acne.
Based on Treatment Type the acne treatment market is bifurcated into medication and therapeutic devices.
In terms of Drug Type, the global acne treatment market has been divided into OTC and prescription.
In terms of acne treatment market has been segregated into hospitals & clinics and specialty centers.
Regional Analysis

Geographically, the global acne treatment market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas drove the acne treatment market in 2019 and is probably going to keep on directing during the survey time frame. This can be credited to the high predominance of acne and skin problems, item dispatches, and mechanical progression around here.

Europe stood firm on the second-biggest foothold in the acne treatment market in 2019 inferable from the natural development systems of organizations and a very much created clinical industry in the area.
The Asia Pacific is expected to register the fastest market growth during the review period followed by the Middle East and Africa.
Major Players
The Key Companies of the global acne treatment market are GlaxoSmithKline plc., Almirall, S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation, and Vyne Therapeutics Inc.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 18 1.1 OVERVIEW 18 1.1.1 MARKET SYNOPSIS 18 2 MARKET INTRODUCTION 19 2.1 SCOPE OF THE STUDY 19 2.2 RESEARCH OBJECTIVE 19 2.3 LIST OF ASSUMPTIONS & LIMITATIONS 19 3 RESEARCH METHODOLOGY 21 3.1 OVERVIEW 21 3.2 DATA MINING 21 3.3 SECONDARY RESEARCH 22 3.4 PRIMARY RESEARCH 23 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24 3.5 FORECASTING TECHNIQUES 25 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25 3.6.1 BOTTOM-UP APPROACH 26 3.6.2 TOP-DOWN APPROACH 27 3.7 DATA TRIANGULATION 28 3.8 VALIDATION 28 4 MARKET DYNAMICS 29 4.1 OVERVIEW 29 4.2 DRIVERS 30 4.2.1 HIGH GLOBAL ACNE PREVALENCE 30 4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 30 4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 30 4.2.4 RISE IN THE DISPOSABLE INCOMES OF MIDDLE-CLASS PEOPLE 31 4.3 RESTRAINTS 32 4.3.1 SAFETY ISSUES REGARDING THE PRODUCTS 32 4.3.2 FAILURE OF PIVOTAL CLINICAL TRIALS FOR KEY CANDIDATES 32 4.4 OPPORTUNITIES 33 4.4.1 INCREASING AWARENESS ABOUT CURRENT AND UPCOMING ACNE TREATMENTS 33 4.5 TRENDS 33 4.5.1 ARTIFICIAL INTELLIGENCE ALGORITHM 33 4.5.2 PREFERENCE TOWARDS CLEAN SKINCARE ROUTINE 34 5 MARKET FACTOR ANALYSIS 35 5.1 VALUE CHAIN ANALYSIS 35 5.1.1 R&D AND DESIGNING 36 5.1.2 MANUFACTURING 36 5.1.3 DISTRIBUTION 36 5.1.4 MARKETING & SALES 36 5.2 PORTER’S FIVE FORCES MODEL 36 5.2.1 BARGAINING POWER OF SUPPLIERS 37 5.2.2 BARGAINING POWER OF BUYERS 37 5.2.3 THREAT OF NEW ENTRANTS 38 5.2.4 THREAT OF SUBSTITUTES 38 5.2.5 INTENSITY OF RIVALRY 38 5.3 IMPACT OF COVID-19 38 5.4 PESTEL ANALYSIS 40 6 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE 41 6.1 OVERVIEW 41 6.2 MODERATE ACNE 42 6.3 MILD ACNE 43 6.4 MODERATE TO SEVERE ACNE 43 7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT 44 7.1 OVERVIEW 44 7.2 MEDICATION 45 7.3 THERAPEUTIC DEVICES 46 8 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE 48 8.1 OVERVIEW 48 8.2 OTC 49 8.3 PRESCRIPTION 49 9 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 50 9.1 OVERVIEW 50 9.2 TOPICAL 51 9.3 ORAL 51 9.4 INJECTABLE 52 10 GLOBAL ACNE TREATMENT MARKET, BY END USER 53 10.1 OVERVIEW 53 10.2 HOSPITALS & CLINICS 54 10.3 SPECIALTY CENTERS 54 11 GLOBAL ACNE TREATMENT MARKET, BY REGION 55 11.1 OVERVIEW 55 11.2 AMERICAS 56 11.2.1 NORTH AMERICA 59 11.2.1.1 US 62 11.2.1.2 CANADA 65 11.2.2 LATIN AMERICA 67 11.3 EUROPE 70 11.3.1 WESTERN EUROPE 73 11.3.1.1 GERMANY 76 11.3.1.2 FRANCE 79 11.3.1.3 UK 80 11.3.1.4 ITALY 82 11.3.1.5 SPAIN 84 11.3.1.6 REST OF WESTERN EUROPE 86 11.3.2 EASTERN EUROPE 89 11.4 ASIA-PACIFIC 92 11.4.1 CHINA 95 11.4.2 JAPAN 98 11.4.3 INDIA 100 11.4.4 AUSTRALIA 102 11.4.5 SOUTH KOREA 104 11.4.6 REST OF ASIA-PACIFIC 106 11.5 MIDDLE EAST & AFRICA 109 11.5.1 MIDDLE EAST 112 11.5.2 AFRICA 115 12 COMPETITIVE LANDSCAPE 117 12.1 OVERVIEW 117 12.2 LEADING MARKET PLAYERS 117 12.3 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118 12.4 COMPETITIVE BENCHMARKING 119 12.4.1 APPROVAL 120 12.4.2 PRODUCT LAUNCH 120 12.4.3 EXPANSION & ACQUISITION 121 12.4.4 AGREEMENT 121 12.5 LIST OF COMPANIES AND THEIR PRODUCTS FOR ACNE TREATMENT 122 13 COMPANY PROFILES 126 13.1 GLAXOSMITHKLINE PLC 126 13.1.1 COMPANY OVERVIEW 126 13.1.2 FINANCIAL OVERVIEW 127 13.1.3 PRODUCTS/SERVICES OFFERED 127 13.1.4 KEY DEVELOPMENTS 128 13.1.5 SWOT ANALYSIS 128 13.1.6 KEY STRATEGIES 128 13.2 ALMIRALL, S.A. 129 13.2.1 COMPANY OVERVIEW 129 13.2.2 FINANCIAL OVERVIEW 129 13.2.3 PRODUCTS/SERVICES OFFERED 130 13.2.4 ALMIRALL, S.A: KEY DEVELOPMENTS 130 13.2.5 SWOT ANALYSIS 131 13.2.6 KEY STRATEGIES 131 13.3 GALDERMA LABORATORIES, L.P. 132 13.3.1 COMPANY OVERVIEW 132 13.3.2 FINANCIAL OVERVIEW 132 13.3.3 PRODUCTS/SERVICES OFFERED 132 13.3.4 KEY DEVELOPMENTS 133 13.3.5 SWOT ANALYSIS 133 13.3.6 KEY STRATEGIES 133 13.4 F. HOFFMAN LA ROCHE LTD 134 13.4.1 COMPANY OVERVIEW 134 13.4.2 FINANCIAL OVERVIEW 135 13.4.3 PRODUCTS/SERVICES OFFERED 135 13.4.4 KEY DEVELOPMENTS 135 13.4.5 SWOT ANALYSIS 136 13.4.6 KEY STRATEGIES 136 13.5 BAUSCH HEALTH COMPANIES INC. 137 13.5.1 COMPANY OVERVIEW 137 13.5.2 FINANCIAL OVERVIEW 137 13.5.3 PRODUCTS/SERVICES OFFERED 138 13.5.4 KEY DEVELOPMENTS 138 13.5.5 SWOT ANALYSIS 139 13.5.6 KEY STRATEGIES 139 13.6 LEO PHARMA A/S 140 13.6.1 COMPANY OVERVIEW 140 13.6.2 FINANCIAL OVERVIEW 140 13.6.3 PRODUCTS/SERVICES OFFERED 141 13.6.4 KEY DEVELOPMENTS 141 13.6.5 SWOT ANALYSIS 141 13.6.6 KEY STRATEGIES 142 13.7 JOHNSON & JOHNSON SERVICES INC. 143 13.7.1 COMPANY OVERVIEW 143 13.7.2 FINANCIAL OVERVIEW 143 13.7.3 PRODUCTS/SERVICES OFFERED 144 13.7.4 KEY DEVELOPMENTS 144 13.7.5 SWOT ANALYSIS 144 13.7.6 KEY STRATEGIES 145 13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 146 13.8.1 COMPANY OVERVIEW 146 13.8.2 FINANCIAL OVERVIEW 146 13.8.3 PRODUCTS/SERVICES OFFERED 147 13.8.4 KEY DEVELOPMENTS 147 13.8.5 SWOT ANALYSIS 147 13.8.6 KEY STRATEGIES 148 13.9 CANDELA CORPORATION 149 13.9.1 COMPANY OVERVIEW 149 13.9.2 FINANCIAL OVERVIEW 149 13.9.3 PRODUCTS/SERVICES OFFERED 149 13.9.4 KEY DEVELOPMENTS 149 13.9.5 SWOT ANALYSIS 150 13.9.6 KEY STRATEGIES 150 13.10 VYNE THERAPEUTICS INC. 151 13.10.1 COMPANY OVERVIEW 151 13.10.2 FINANCIAL OVERVIEW 151 13.10.3 PRODUCTS/SERVICES OFFERED 151 13.10.4 KEY DEVELOPMENTS 152 13.10.5 SWOT ANALYSIS 152 13.10.6 KEY STRATEGIES 152 14 APPENDIX 153 14.1 REFERENCES 153 14.2 RELATED REPORTS 153

Related products